Agreement between pharmaceutical claims data and patient-reported medication use after stroke.

2021-08-11

Dalli, Lachlan L

Andrew, Nadine E

Cadilhac, Dominique A

Kim, Joosup

Sanfilippo, Frank M

Kilkenny, Monique F

administrative claims

healthcare validation study

pharmacoepidemiology

registries

Stroke

Journal Article

0000-0003-1449-9132

0000-0002-4846-2840

0000-0001-8162-682X

0000-0002-4079-0428

0000-0003-3639-0787

0000-0002-3375-287X

10.1093/ijpp/riab032

To assess the agreement between pharmaceutical claims data and patient-reported medication use after stroke. Claims data from the Pharmaceutical Benefits Scheme were used to estimate medication use for a subset of participants registered in the Australian Stroke Clinical Registry in 2016. Estimates on medication use were validated against patient-reported responses (considered the reference standard). For antihypertensive and lipid-lowering medications, the sensitivity of claims data was excellent (85-87%) and the specificity was good (73-78%). Whereas for antithrombotic medications, sensitivity was modest (61%), but specificity was excellent (85%). Pharmaceutical claims data can be used to infer medication use after stroke with mostly good to excellent sensitivity and specificity compared with the patient report.

link

The International Journal of Pharmacy Practice 2021; 29(4): 397-399

The International Journal of Pharmacy Practice